Neutrophil apoptosis by Fas/FasL: Harmful or advantageous in cardiac surgery?

Thoracic and Cardiovascular Surgeon

Volumn 57, Issue 1, 2009, Pages 1-6

  Kunes, P ^a,b   Krejsek, J ^b   Brtko, M ^a   Mandak, J ^a   Kolackova, M ^b   Kudlova, M Trojackova ^b   Andrys, C ^b  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cardiovascular surgery; Coronary bypass surgery; Heart disease

Indexed keywords

FAS LIGAND; PROTEIN BCL 2; FAS ANTIGEN;

APOPTOSIS; ATHEROSCLEROSIS; CARDIOPULMONARY BYPASS; CELL ACTIVATION; CELL DEATH; CELL FATE; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; ENDOPLASMIC RETICULUM; HEART SURGERY; HUMAN; IMMUNITY; INFECTION; INFLAMMATION; MITOCHONDRION; NEUTROPHIL; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SURGICAL PATIENT; ANIMAL; BACTERIAL INFECTION; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; PATHOLOGY;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; ATHEROSCLEROSIS; BACTERIAL INFECTIONS; CARDIAC SURGICAL PROCEDURES; FAS LIGAND PROTEIN; HUMANS; IMMUNITY, INNATE; INFLAMMATION; NEUTROPHILS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 62449108910     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-2008-1039060     Document Type: Review

References (43)

1. Tomic V, Russwurm S, Möller E et al. Transcriptomic and proteomic pat-terns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting. Circulation 2005;112:2912-2920
2. Ruel M, Bianchi C, Khan TA et al. Gene expression profile after cardio-pulmonary bypass and cardioplegic arrest. J Thorac Cardiovasc Surg 2003;126:1521-1530
3. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell 2004;116:205-219
4. de Cathelineau AM, Henson PM. The final step in programmed cell death: phagocytes carry apoptotic cells to the grave. Essays Biochem 2003;39:105-117
5. Kostin S. Pathways of myocyte death: implications for development of clinical laboratory biomarkers. Adv Clin Chem 2005;40:37-98
6. Krammer PH. CD95 (APO-1/Fas) -mediated apoptosis: live and let die. Adv Immunol 1999;71:163-210
7. Aouad SM, Cohen LY, Sharif-Askari E et al. Caspase-3 is a component of Fas death-inducing signaling complex in lipid rafts and its activity is required for complete caspase-8 activation during Fas-mediated cell death. J Immunol 2004;172:2316-2323
8. Guo R-F, Sun L, Gao H et al. In vivo regulation of neutrophil apoptosis by C5a during sepsis. J Leukocyte Biol 2006;80:1575-1583
9. Gustafsson AB, Gottlieb RA. Bcl-2 family members of apoptosis, taken to heart. Am J Physiol 2006;292: C45-C51
10. Zou H, Li Y, Liu X, Wang X. An APAF1-cytochrome c multimeric com-plex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999;274:11549-11556
11. Kokkonen TS, Augustin MT, Mäkinen JM et al. High endothelial venules of the lymph nodes express Fas ligand. J Histochem Cytochem 2004;52:693-700
12. Arens R, Baars PA, Jak M et al. CD95 maintains effector T cell homeo-stasis in chronic immune activation. J Immunol 2005;174:5915-5920
13. Unsinger J, Herndon JM, Davis CG et al. The role of TCR engagement and activation-induced cell death in sepsis-induced T cell apoptosis. J Immunol 2006;177:7968-7973
14. Pletz MWR, Ioanas M, de Roux A et al. Reduced spontaneous apoptosis in peripheral blood neutrophils during exacerbation of COPD. Eur Respir J 2004;23:532-537
15. Garlichs CD, Eskafi S, Cicha I et al. Delay of neutrophil apoptosis in acute coronary syndromes. J Leukocyte Biol 2004;75:828-835
16. Power CP, Wang JH, Manning B et al. Bacterial lipoprotein delays apop-tosis in human neutrophils through inhibition of caspase-3 activity: regulatory roles for CD14 and TLR-2. J Immunol 2004;173:5229-5237
17. Alvarez ME, Bass JIF, Geffner JR et al. Neutrophil signaling pathways ac-tivated by bacterial DNA stimulation. J Immunol 2006;177:4037-4046
18. Lee K-H, Feig C, Tchikov V et al. The role of receptor internalization in CD95 signaling. EMBO J 2006;25:1009-1023
19. Ankersmit HJ, Weber T, Auer J et al. Increased serum concentrations of soluble CD95/Fas and caspase 1/ICE in patients with acute angina. Heart 2004;90:151-154
20. Blanco-Colio LM, Martín-Ventura JL, de Teresa E et al. Increased soluble Fas plasma levels in subjects at high cardiovascular risk. Atorvastatin on Inflammatory Markers (AIM) study, a substudy of ACTFAST. Arte-rioscler Thromb Vasc Biol 2007;27:168-174
21. van der Meer IM, Oei H-HS, Hofman A et al. Soluble Fas, a mediator of apoptosis, C-reactive protein, and coronary and extracoronary athero-sclerosis. The Rotterdam Coronary Calcification Study. Atherosclerosis 2006;189:464-469
22. Wang T, Dong C, Stevenson SC et al. Overexpression of soluble Fas at-tenuates transplant arteriosclerosis in rat aortic allografts. Circulation 2002;106:1536-1542
23. Nishigaki K, Minatoguchi S, Seishima M et al. Plasma Fas ligand, an in-ducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. J Am Coll Cardiol 1997;29:1214-1220
24. Peter ME, Budd RC, Desbarats J et al. The CD95 receptor: apoptosis re-visited. Cell 2007;129:447-450
25. Kolodgie FD, Narula J, Burke AP et al. Localization of apoptotic macro-phages at the site of plaque rupture in sudden coronary death. Am J Pathol 2000;157:1259-1268
26. Bowen-Pope DF, Schaub FJ. Apoptosis of smooth muscle cells is not si-lent: Fas/FADD initiates a program of inflammatory gene expression. Trends Cardiovasc Med 2001;11:42-45
27. Yang J, Sato K, Aprahamian T et al. Endothelial overexpression of Fas li-gand decreases atherosclerosis in apolipoprotein E-deficient mice. Ar-terioscler Thromb Vasc Biol 2004;24:1466-1473
28. Walsh K, Sata M. Negative regulation of inflammation by Fas ligand expression on the vascular endothelium. Trends Cardiovasc Med 1999;9:34-41
29. Sata M, Walsh K. TNF-α regulation of Fas ligand expression on the vas-cular endothelium modulates leukocyte extravasation. Nat Med 1998;4:415-420
30. Sata M, Walsh K. Oxidized LDL activates Fas-mediated endothelial cell apoptosis. J Clin Invest 1998;102:1682-1689
31. Boyle JJ, Bowyer DE, Weissberg PL, Bennett MR. Human blood-derived macrophages induce apoptosis in human plaque-derived vascular smooth muscle cells by Fas-ligand/Fas interactions. Arterioscler Thromb Vasc Biol 2001;21:1402-1407
32. Wesche DE, Lomas-Neira JL, Perl M et al. Leukocyte apoptosis and its significance in sepsis and shock. J Leukocyte Biol 2005;78:325-337
33. Leuenroth S, Lee C, Grutkoski P, Keeping H, Simms H. Interleukin-8-in-duced suppression of polymorphonuclear leukocyte apoptosis is mediated by suppressing CD95 (Fas/Apo-1) Fas-L interactions. Sur-gery 1998;124:409-417
34. Ramlawi B, Feng J, Mieno S et al. Indices of apoptosis activation after blood cardioplegia and cardiopulmonary bypass. Circulation 2006;114(Suppl. 1) : I257-263
35. Jimenez MF, Watson WG, Parodo J et al. Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syn-drome. Arch Surg 1997;132:1263-1270
36. Greenstein S, Barnard J, Zhou K et al. Fas activation reduces neutrophil adhesion to endothelial cells. J Leukocyte Biol 2000;68:715-722
37. Negrotto S, Malaver E, Alvarez ME et al. Aspirin and salycylate suppress polymorphonuclear apoptosis delay mediated by proinflammatory stimuli. J Pharmacol Exp Therap 2006;319:972-979
38. Collard CD, Body SC, Shernan SK et al. Preoperative statin therapy is as-sociated with reduced cardiac mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2006;132:392-400
39. Chello M, Anselmi A, Spadaccio C et al. Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery. Ann Thorac Surg 2007;83:1374-1380
40. O'Neil-Callahan K, Katsimaglis G, Tepper MR et al. Statins decrease peri-operative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. J Am Coll Cardiol 2005;45:336-342
41. Scholz M, Simon A, Berg M et al. In vivo inhibition of neutrophil activity by a Fas (CD95) stimulating molecule: arterial in-line application in a porcine cardiac surgery model. J Thorac Cardiovasc Surg 2004;127:1735-1742
42. Akao M, O'Rourke B, Teshima Y et al. Mechanistically distinct steps in the mitochondrial death pathway triggered by oxidative stress in car-diac myocytes. Circ Res 2003;92:186-194
43. Del Re DP, Miyamoto S, Brown JH. RhoA/Rho kinase upregulate Bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis. J Biol Chem 2007;282:8069-8078